Researchers have identified a biochemical pathway that destabilizes spines in knock-in mice bearing a protein linked to some cases of familial Alzheimer’s disease (AD). The work suggests a novel therapeutic approach to AD and age-related memory loss that is independent of the amyloid-beta processing approaches at the oft-broken heart of current drug trials.